These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27313195)

  • 1. GLP-1 is not the key mediator of the health benefits of metabolic surgery.
    Vidal J; de Hollanda A; Jiménez A
    Surg Obes Relat Dis; 2016 Jul; 12(6):1225-9. PubMed ID: 27313195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor.
    Holst JJ; Madsbad S
    Surg Obes Relat Dis; 2016 Jul; 12(6):1236-42. PubMed ID: 27313194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication.
    Casajoana A; Pujol J; Garcia A; Elvira J; Virgili N; de Oca FJ; Duran X; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Obes Surg; 2017 Sep; 27(9):2235-2245. PubMed ID: 28451931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe.
    Salehi M; D'Alessio DA
    Surg Obes Relat Dis; 2016 Jul; 12(6):1230-5. PubMed ID: 27568473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it?
    Smith EP; Polanco G; Yaqub A; Salehi M
    Metabolism; 2018 Jun; 83():159-166. PubMed ID: 29113813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes.
    Rhee NA; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2012 Apr; 14(4):291-8. PubMed ID: 21951387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
    Qiu NC; Zhang Q; Song X; Liu ME; Li XK; Shan CX; Qiu M
    J Surg Res; 2014 Sep; 191(1):123-9. PubMed ID: 24768143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effects of GLP-1 Agonists, Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Diabetes Mellitus Outcomes.
    Essop T; Tran K; Purdy AC; Daly SC
    Curr Diab Rep; 2024 Dec; 24(12):273-289. PubMed ID: 39325334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.
    Peterli R; Wölnerhanssen B; Peters T; Devaux N; Kern B; Christoffel-Courtin C; Drewe J; von Flüe M; Beglinger C
    Ann Surg; 2009 Aug; 250(2):234-41. PubMed ID: 19638921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?
    Manning S; Pucci A; Batterham RL
    Physiology (Bethesda); 2015 Jan; 30(1):50-62. PubMed ID: 25559155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Viaplana J; Corcelles R; Lacy A; Vidal J
    Ann Surg; 2012 Dec; 256(6):1023-9. PubMed ID: 22968072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Lessons from the gut: Studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy.
    Holst JJ; Madsbad S; Bojsen-Møller KN; Dirksen C; Svane M
    Peptides; 2024 Jun; 176():171199. PubMed ID: 38552903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in weight loss surgery and gastrointestinal peptides.
    Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):21-8. PubMed ID: 25517025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes remission following metabolic surgery: is GLP-1 the culprit?
    Vidal J; Jiménez A
    Curr Atheroscler Rep; 2013 Oct; 15(10):357. PubMed ID: 23955665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of GLP-1 in the Metabolic Success of Bariatric Surgery.
    Hutch CR; Sandoval D
    Endocrinology; 2017 Dec; 158(12):4139-4151. PubMed ID: 29040429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pilot Study Examining the Effects of GLP-1 Receptor Blockade Using Exendin-(9,39) on Gastric Emptying and Caloric Intake in Subjects With and Without Bariatric Surgery.
    Kittah E; Camilleri M; Jensen MD; Vella A
    Metab Syndr Relat Disord; 2020 Nov; 18(9):406-412. PubMed ID: 32833560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.